A 5‐year experience of lipiodolization: Selective regional chemotherapy for 200 patients with hepatocellular carcinoma
Takashi Kanematsu, Toshiya Furuta, Kenji Takenaka, Takashi Matsumata, Yasuhiro Yoshida, Takashi Nishizaki, Kanehiro Hasuo, Keizo Sugimachi – 1 July 1989 – Between 1982 and 1987, selective regional cancer chemotherapy using Lipiodol plus an anticancer drug (lipiodolization) was prescribed for 200 patients with hepatocellular carcinoma. One hundred forty‐nine patients were given lipiodolization alone, and the remaining 51 underwent hepatic resection following lipiodolization.